148 related articles for article (PubMed ID: 38435757)
1. The Japanese Version of the Daily Record of Severity of Problems for Premenstrual Symptoms: Reliability and Validity Among the General Japanese Population.
Takeda T; Yoshimi K; Kai S; Inoue F
Int J Womens Health; 2024; 16():299-308. PubMed ID: 38435757
[TBL] [Abstract][Full Text] [Related]
2. Psychometric Testing of the Japanese Version of the Daily Record of Severity of Problems Among Japanese Women.
Takeda T; Kai S; Yoshimi K
Int J Womens Health; 2021; 13():361-367. PubMed ID: 33833588
[TBL] [Abstract][Full Text] [Related]
3. The reliability and validity of the Japanese version of the Daily Record of Severity of Problems (J-DRSP) and Development of a Short-Form version (J-DRSP (SF)) to assess symptoms of premenstrual syndrome among Japanese women.
Ikeda Y; Egawa M; Okamoto K; Mandai M; Takahashi Y; Nakayama T
Biopsychosoc Med; 2021 Mar; 15(1):6. PubMed ID: 33736660
[TBL] [Abstract][Full Text] [Related]
4. Development of a Japanese Version of the Daily Record of Severity of Problems for Diagnosing Premenstrual Syndrome.
Ikeda Y; Egawa M; Hiyoshi K; Ueno T; Ueda K; Becker CB; Takahashi Y; Nakayama T; Mandai M
Womens Health Rep (New Rochelle); 2020; 1(1):11-16. PubMed ID: 33786468
[No Abstract] [Full Text] [Related]
5. Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).
Henz A; Ferreira CF; Oderich CL; Gallon CW; Castro JRS; Conzatti M; Fleck MPA; Wender MCO
Rev Bras Ginecol Obstet; 2018 Jan; 40(1):20-25. PubMed ID: 29132173
[TBL] [Abstract][Full Text] [Related]
6. Correction to: The reliability and validity of the Japanese version of the daily record of severity of problems (J-DRSP) and development of a short-form version (J-DRSP (SF)) to assess symptoms of premenstrual syndrome among Japanese women.
Ikeda Y; Egawa M; Okamoto K; Mandai M; Takahashi Y; Nakayama T
Biopsychosoc Med; 2021 Dec; 15(1):27. PubMed ID: 34972535
[No Abstract] [Full Text] [Related]
7. Treatment of premenstrual dysphoric disorder with the GABA
Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
[TBL] [Abstract][Full Text] [Related]
8. Psychometric Testing of the Premenstrual Symptoms Questionnaire and the Association Between Perceived Injustice and Premenstrual Symptoms: A Cross-Sectional Study Among Japanese High School Students.
Takeda T; Yoshimi K; Yamada K
Int J Womens Health; 2020; 12():755-763. PubMed ID: 33061664
[TBL] [Abstract][Full Text] [Related]
9. Daily Record of Severity of Problems (DRSP): reliability and validity.
Endicott J; Nee J; Harrison W
Arch Womens Ment Health; 2006 Jan; 9(1):41-9. PubMed ID: 16172836
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of ethinylestradiol/drospirenone for premenstrual symptoms in Japanese patients with dysmenorrhea: Open-label pilot study.
Takeda T; Kondo A; Koga S; Hayakawa J; Hayakawa K; Hiramatsu K; Yaegashi N
J Obstet Gynaecol Res; 2015 Oct; 41(10):1584-90. PubMed ID: 26310836
[TBL] [Abstract][Full Text] [Related]
11. Chinese version of Daily Record of Severity of Problems: reliability and validity.
Wu L; He Z; Zhao H; Ma D; Zhang S; Deng H; Liang T
J Adv Nurs; 2013 Feb; 69(2):449-56. PubMed ID: 22737971
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder.
Bäckström T; Ekberg K; Hirschberg AL; Bixo M; Epperson CN; Briggs P; Panay N; O'Brien S
Psychoneuroendocrinology; 2021 Nov; 133():105426. PubMed ID: 34597899
[TBL] [Abstract][Full Text] [Related]
13. Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.
Comasco E; Kopp Kallner H; Bixo M; Hirschberg AL; Nyback S; de Grauw H; Epperson CN; Sundström-Poromaa I
Am J Psychiatry; 2021 Mar; 178(3):256-265. PubMed ID: 33297719
[TBL] [Abstract][Full Text] [Related]
14. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
[TBL] [Abstract][Full Text] [Related]
15. A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS).
Frey BN; Allega OR; Eltayebani M; Syan SK; Mendes-Ribeiro J; Minuzzi L
BMC Womens Health; 2022 Mar; 22(1):96. PubMed ID: 35354450
[TBL] [Abstract][Full Text] [Related]
16. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
[TBL] [Abstract][Full Text] [Related]
17. Assessment of premenstrual symptoms: validation of the Italian version of the Premenstrual Symptoms Screening Tool.
Pacitti F; Iorio C; Riccobono G; Iannitelli A; Pompili A
Riv Psichiatr; 2021; 56(5):246-253. PubMed ID: 34663991
[TBL] [Abstract][Full Text] [Related]
18. Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).
Eisenlohr-Moul TA; Girdler SS; Schmalenberger KM; Dawson DN; Surana P; Johnson JL; Rubinow DR
Am J Psychiatry; 2017 Jan; 174(1):51-59. PubMed ID: 27523500
[TBL] [Abstract][Full Text] [Related]
19. Development and Psychometric Testing of a New Short-Form of the Premenstrual Symptoms Questionnaire (PSQ-S).
Takeda T; Yoshimi K; Kai S; Inoue F
Int J Womens Health; 2022; 14():899-911. PubMed ID: 35860717
[TBL] [Abstract][Full Text] [Related]
20. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis.
Cheung PWH; Wong CKH; Samartzis D; Luk KDK; Lam CLK; Cheung KMC; Cheung JPY
Scoliosis Spinal Disord; 2016; 11():19. PubMed ID: 27525314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
